Thank you for donating!

You can donate using the following services.

News

  1. 28.08.20

    Cyclo Therapeutics Closes $2.8 Million Private Placement Led by Novit LP with $1.0 Million

    GAINESVILLE, FL – (BusinessWire) – August 27, 2020 – Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC) and Alzheimer’s Disease, today announced that it has closed a private placement of its securities with a group of accredited investors...

    Read more
  2. 21.08.20

    Digital Annual Family Conference & Interactive Workshop 2020 (REGISTER NOW!)

    We are excited to announce that registration for our very first Digital Annual Family Conference & Interactive Workshop on Niemann-Pick Disease, is now open!

    Read more
  3. 20.07.20

    Orphazyme completes rolling submission of New Drug Application to U.S. FDA for arimoclomol for Niemann-Pick disease Type C

    Read more
  4. 09.07.20

    UK LSD Collaborative: Survey 2020

    Read more
  5. 23.06.20

    Revised Guidance on Shielding (NPUK Statement)

    With the risk of catching coronavirus steadily decreasing, the UK Government yesterday announced changes to the future of the shielding programme. From 6 July those shielding will be able to meet outdoors, in groups of up to six people from outside their household, with social distancing. If you live alone (or are a lone adult with dependent children under 18), you will be able to form a support bubble with another household. From 1 August, many people will no longer need to shield, and the advice will be that you can visit shops and places of worship, but you should continue to maintain social distancing whenever possible...

    Read more